MiR-101a and miR-30b contribute to inflammatory cytokine-mediated β-cell dysfunction

Laboratory Investigation

Volumn 95, Issue 12, 2015, Pages 1387-1397

  Zheng, Ying ^a   Wang, Zhen ^b   Tu, Yiting ^b   Shen, Hongwei ^a   Dai, Zhijie ^b   Lin, Jian ^b   Zhou, Zhiguang ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 101A; MICRORNA 146A; MICRORNA 21; MICRORNA 30B; MICRORNA 34A; NEUROGENIC DIFFERENTIATION FACTOR; PROINSULIN; PROTEIN BCL 2; STAT3 PROTEIN; TRANSCRIPTION FACTOR ONECUT; TRANSCRIPTION FACTOR ONECUT2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CYTOKINE; HOMEODOMAIN PROTEIN; INSULIN; MIRN101 MICRORNA, HUMAN; MIRN30 MICRORNA, HUMAN; NEUROD1 PROTEIN, HUMAN; ONECUT2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BINDING SITE; CELL COUNT; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SYNTHESIS; MIN6 CELL LINE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN TARGETING; RNA ANALYSIS; RNA SEQUENCE; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; DIABETES MELLITUS, TYPE 1; METABOLISM; SECRETION (PROCESS);

ANIMALS; APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CYTOKINES; DIABETES MELLITUS, TYPE 1; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICRORNAS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSCRIPTION FACTORS;

EID: 84948464637     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2015.112     Document Type: Article

References (35)

1. Zhang L, Gianani R, Nakayama M et al. Type 1 diabetes: chronic progressive autoimmune disease. Novartis Found Symp 2008;292:85-94
2. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 2009;5:219-226
3. McDaniel ML, Kwon G, Hill JR et al. Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med 1996;211:24-32
4. Donath MY, Storling J, Berchtold LA et al. Cytokines and beta-cell biology: from concept to clinical translation. Endocr Rev 2008;29:334-350
5. Bartel DP. Micrornas: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297
6. Guo H, Ingolia NT, Weissman JS et al. Mammalian micrornas predominantly act to decrease target mrna levels. Nature 2010;466: 835-840
7. Chang TC, Mendell JT. Micrornas in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet 2007;8:215-239
8. Poy MN, Eliasson L, Krutzfeldt J et al. A pancreatic islet-specific Micro RNA regulates insulin secretion. Nature 2004;432:226-230
9. Plaisance V, Abderrahmani A, Perret-Menoud V et al. Microrna-9 controls the expression of granuphilin/slp4 and the secretory response of insulin-producing cells. J Biol Chem 2006;281:26932-26942
10. Baroukh N, Ravier MA, Loder MK et al. Microrna-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. J Biol Chem 2007;282:19575-19588
11. Lovis P, Gattesco S, Regazzi R. Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by micrornas. Biol Chem 2008;389:305-312
12. El Ouaamari A, Baroukh N, Martens GA et al. Mir-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucoseinduced biological responses in pancreatic beta-cells. Diabetes 2008;57:2708-2717
13. Lovis P, Roggli E, Laybutt DR et al. Alterations in Micro RNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 2008;57:2728-2736
14. Roggli E, Britan A, Gattesco S et al. Involvement of micrornas in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes 2010;59:978-986
15. Roggli E, Gattesco S, Caille D et al. Changes in Micro RNA expression contribute to pancreatic beta-cell dysfunction in prediabetic Nod mice. Diabetes 2012;61:1742-1751
16. Ortis F, Miani M, Colli ML et al. Differential usage of Nf-Kappa b activating signals by Il-1beta and Tnf-alpha in pancreatic beta cells. FEBS Lett 2012;586:984-989
17. Loweth AC, Williams GT, James RF et al. Human islets of langerhans express fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation. Diabetes 1998;47:727-732
18. Flodstrom M, Welsh N, Eizirik DL. Cytokines activate the nuclear factor kappa B (Nf-Kappa B) and induce nitric oxide production in human pancreatic islets. FEBS Lett 1996;385:4-6
19. Yang J, Lu YW, Lu MM et al. Microrna-101, mitogen-activated protein kinases and mitogen-activated protein kinases phosphatase-1 in systemic lupus erythematosus. Lupus 2013;22:115-120
20. Zhu QY, Liu Q, Chen JX et al. Microrna-101 targets Mapk phosphatase-1 to regulate the activation of Mapks in macrophages. J Immunol 2010;185:7435-7442
21. Wei C, Li L, Gupta S. Nf-kappab-mediated Mir-30b regulation in cardiomyocytes cell death by targeting Bcl-2. Mol Cell Biochem 2014;387:135-141
22. Andrali SS, Sampley ML, Vanderford NL et al. Glucose regulation of insulin gene expression in pancreatic beta-cells. Biochem J 2008;415:1-10
23. Petersen HV, Serup P, Leonard J et al. Transcriptional regulation of the human insulin gene is dependent on the homeodomain protein Stf1/ Ipf1 acting through the Ct boxes. Proc Natl Acad Sci USA 1994;91: 10465-10469
24. Naya FJ, Stellrecht CM, Tsai MJ. Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev 1995;9:1009-1019
25. Kaneto H, Miyatsuka T, Kawamori D et al. Pdx-1 and Mafa play a crucial role in pancreatic beta-cell differentiation and maintenance of mature beta-cell funcation. Endocr J 2008;55:235-252
26. Iguchi H, Ikeda Y, Okamura M et al. Sox6 attenuates glucose-stimulated insulin secretion by repressing pdx1 transcriptional activity and is down-regulated in hyperinsulinemic obese mice. J Biol Chem 2005;280:37669-37680
27. Inada A, Yamada Y, Someya Y et al. Transcriptional repressors are increased in pancreatic islets of type 2 diabetic rats. Biochem Biophys Res Commun 1998;253:712-718
28. Jensen J, Pedersen EE, Galante P et al. Control of endodermal endocrine development by Hes-1. Nat Genet 2000;24:36-44
29. Cheviet S, Waselle L, Regazzi R. Noc-king out exocrine and endocrine secretion. Trends Cell Biol 2004;14:525-528
30. Lang J. Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. Eur J Biochem 1999;259:3-17
31. Youle RJ, Strasser A. The Bcl-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008;9:47-59
32. Gurzov EN, Ortis F, Cunha DA et al. Signaling by Il-1beta+Ifn-gamma and Er stress converge on Dp5/Hrk activation: a novel mechanism for pancreatic beta-cell apoptosis. Cell Death Differ 2009;16:1539-1550
33. Gurzov EN, Eizirik DL. Bcl-2 proteins in diabetes: mitochondrial pathways of beta-cell death and dysfunction. Trends Cell Biol 2011;21:424-431
34. Akerfeldt MC, Howes J, Chan JY et al. Cytokine-induced beta-cell death is independent of endoplasmic reticulum stress signaling. Diabetes 2008;57:3034-3044
35. Koukos G, Polytarchou C, Kaplan JL et al. Microrna-124 regulates Stat3 expression and Is down-regulated in colon tissues of pediatric patients with ulcerative colitis. Gastroenterology 2013;145:842-852